强化具有高丁转运量的益生菌,以有效管理高尿路血症
Zhen-Ping Zou1, Ju-Ling Li1, Yi-Fan Zhang1
1Laboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, Institute of Engineering Biology and Health, East China University of Science and Technology, Shanghai, China.
Gut microbes
|September 17, 2024
概括
工程化益生菌提供了一种新的方法,通过减少纯素吸收来管理高尿血症. 这种新菌株有效降低血清尿酸,改善功能,副作用比传统药物少.
科学领域:
- 微生物学和代谢障碍 微生物学和代谢障碍
- 基因工程和益生菌治疗学
背景情况:
- 超尿血是常见的代谢疾病,与严重的健康并发症有关.
- 目前的高尿血症治疗有显著的不良影响,需要更安全的替代方案.
研究的目的:
- 开发和评估一种新的益生菌策略,用于治疗高尿血症.
- 评估工程益生菌在降低血清尿酸水平方面的有效性和安全性.
主要方法:
- 设计了一个益生菌 *Escherichia coli* 尼斯尔1917菌株 (YES301) 与一个山丁进口剂 (XanQ).
- 向超尿血症的小鼠模型注射YAS301以评估其对尿酸水平和功能的影响.
- 与YAS301的治疗效果和生物安全性进行了比较,与allopurinol相比.
主要成果:
- YES301有效地进口了山丁和低山丁,导致尿酸度降低.
- 工程化益生菌改善了高尿血症模型中的功能障碍.
- YES301的疗效与阿洛普林醇相当,但生物安全性提高,副作用较少.
结论:
- 像YES301这样的工程益生菌代表了对高尿路血的有希望的治疗途径.
- 这种方法有效降低肠道纯素水平,为管理代谢障碍提供了一种新的策略.
- YES301显示出作为传统高尿路血症治疗的安全有效替代品的潜力.
相关概念视频
Drug Elimination by Renal Route: Tubular Secretion
2.2K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.2K
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Enhanced Elimination of Poison
486
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
486
Renal Drug Excretion: Tubular Secretion
152
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
152
Carrier-Mediated Transport
310
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
310
Drug Metabolism: Phase II Reactions
3.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.7K


